133 related articles for article (PubMed ID: 24184540)
21. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
23. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
24. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.
Shu XS; Geng H; Li L; Ying J; Ma C; Wang Y; Poon FF; Wang X; Ying Y; Yeo W; Srivastava G; Tsao SW; Yu J; Sung JJ; Huang S; Chan AT; Tao Q
PLoS One; 2011; 6(11):e27346. PubMed ID: 22087297
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma.
Peng L; Yang Z; Tan C; Ren G; Chen J
Mol Med Rep; 2013 Mar; 7(3):1055-61. PubMed ID: 23358566
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
28. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
Lee KY; Geng H; Ng KM; Yu J; van Hasselt A; Cao Y; Zeng YX; Wong AH; Wang X; Ying J; Srivastava G; Lung ML; Wang LD; Kwok TT; Levi BZ; Chan AT; Sung JJ; Tao Q
Oncogene; 2008 Sep; 27(39):5267-76. PubMed ID: 18469857
[TBL] [Abstract][Full Text] [Related]
30. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
31. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
32. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer.
Moncada-Pazos A; Obaya AJ; Fraga MF; Viloria CG; Capellá G; Gausachs M; Esteller M; López-Otín C; Cal S
J Cell Sci; 2009 Aug; 122(Pt 16):2906-13. PubMed ID: 19638407
[TBL] [Abstract][Full Text] [Related]
33. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
34. Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.
Yue Y; Yuan Y; Li L; Fan J; Li C; Peng W; Ren G
Int J Mol Med; 2018 May; 41(5):2986-2996. PubMed ID: 29436596
[TBL] [Abstract][Full Text] [Related]
35. ADAMTS8 inhibited lung cancer progression through suppressing VEGFA.
Zhang Y; Hu K; Qu Z; Xie Z; Tian F
Biochem Biophys Res Commun; 2022 Apr; 598():1-8. PubMed ID: 35149432
[TBL] [Abstract][Full Text] [Related]
36. ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma.
Porter S; Span PN; Sweep FC; Tjan-Heijnen VC; Pennington CJ; Pedersen TX; Johnsen M; Lund LR; Rømer J; Edwards DR
Int J Cancer; 2006 Mar; 118(5):1241-7. PubMed ID: 16152618
[TBL] [Abstract][Full Text] [Related]
37. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
[TBL] [Abstract][Full Text] [Related]
38. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas.
Cheng Y; Geng H; Cheng SH; Liang P; Bai Y; Li J; Srivastava G; Ng MH; Fukagawa T; Wu X; Chan AT; Tao Q
Cancer Res; 2010 Aug; 70(16):6516-26. PubMed ID: 20682794
[TBL] [Abstract][Full Text] [Related]
39. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
[TBL] [Abstract][Full Text] [Related]
40. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
